Ferritin-fused LL-37 outperforms free peptide in murine sepsis model
Fusing LL-37 to ferritin light chain aimed to resist proteolysis and target macrophage scavenger receptor A at inflammatory sites.
PR
By Priya Raman · Science Reporter
Aug 30 20:00 ETSource: International journal of biological macromolecules
The wire
- 01Researchers fused LL-37 to the C-terminus of ferritin light chain; the construct retained antimicrobial activity and showed better antibacterial and anti-inflammatory effect than free LL-37 in mice with sepsis.
- 02LL-37's poor stability and rapid degradation are the main barriers readers following the peptide have tracked; a carrier fusion is one route around them.
- 03Safety testing reported no significant hemolysis, immunogenicity or tissue toxicity, but this is a mouse model with no human data and no clinical program described.
From the source
Read at pubmed.ncbi.nlm.nih.govTargeted delivery of antimicrobial peptide LL-37 via ferritin fusion improves antibacterial and anti-inflammatory outcomes in a murine sepsis model
International journal of biological macromolecules · 2026 Aug 31 · Pan W, Tian C, Ding Y et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42669340/